--- a
+++ b/clusters/9knumclustersv2/clust_1294.txt
@@ -0,0 +1,67 @@
+Male or female patients aged ? years
+Male subjects must:
+Male or female patients aged ?  years.
+Male or female aged ?  years
+Male or female subjects
+Adult male or female participants aged >= years (Japan) or >= years (United States).
+Male or female patients aged ?  years at time of informed consent;
+Male or female aged ?  years;
+Male or female participant
+Male or female aged ? years.
+Male or female, aged at least  years.
+Male patients
+Gender: male and female
+Male/female sterilization
+All male and female subjects must follow all requirements defined in the Pregnancy Prevention Program.
+Male and female subjects
+Male or female subjects aged greater than or equal to (>=)  years
+Male and female subjects
+Male patients.
+Male subjects must :
+Male or female subjects aged ? years
+Male or non-pregnant, non-breastfeeding female at least  years of age. Patients aged at ~ years may be recruited but only at the site principle investigator's request and subject to IRB approval.
+Male or Female
+Male or female patients aged  -  years.
+Male or female subjects aged greater than or equal to (>=)  years
+Male or female subjects aged ? years
+Subjects may be male or female, and must be aged =/> years on the date of signing the informed consent form.
+Male or female subjects aged ? years
+Male or female subjects aged >/=  years.
+Patient is male or female aged ? years.
+Male or female, aged at least  years.
+Male or non-pregnant female
+Sex: male or female.
+Male or female subjects aged greater than or equal to (>=)  years
+Male and female subjects aged greater than  years
+Male or female patients aged >/=  years old
+Male subjects must:
+Male or female participants aged ? years at the time of screening
+Male or female subjects aged >  years
+Male and female subjects aged  to  years, inclusive.
+Male or female aged ?  years
+Male or female subjects aged ? years (or country-specific legal age of maturity, if > years)
+Male or female, and:
+Male or female
+Male or female subjects aged =/>  years
+Male and female subjects
+Male or Female (non-pregnant)
+Male or female subjects aged >/= years
+Male or female aged ?  years
+Male or female subjects aged >/= years
+Male and female patients aged ?  years.
+Male or female participants aged  to < years ( to < years for Hodgkin lymphoma [HL])
+Male or female aged  years; a female is eligible to enter and participate in the study if she is:
+Male Patients:
+Male or female patients aged > years
+Male gender
+Male patients
+Male and female patients aged  to  years, inclusive;
+Male subjects must:
+Male subjects must:
+Male or Female
+Men with a history of at least one male sexual partner            \r\n* Men is defined as those documented male at birth (including male-to-female transgendered persons)
+Participant can be a male or a non-pregnant female
+Male patients
+Male or female patients
+The patient is male
+Male or female aged -